Ahr-depleted mice developed more aggressive tumors than their wild-type counterparts in the transgenic adenocarcinoma of the mouse prostate model 166 and showed increased liver tumors induced by diethylnitrosamine in male mice compared with their wild-type AHR littermates 167. The gene discussed is AHR; the disease is adenocarcinoma.